BioMedNewsBreaks — Astiva Health Earns 2026 Senior Choice Gold Award for Excellence in Medicare Advantage Performance and Value

Company: Astiva Health
Category: News

Astiva Health, a rapidly growing Medicare Advantage organization serving California’s diverse senior population, has been awarded the 2026 Senior Choice Gold Award by HealthMetrix Research Inc., recognizing its superior cost-effective coverage and culturally aligned care model. With a 4-star CMS quality rating and more than 38,000 members across the state, Astiva continues to lead in delivering high-value, community-based healthcare—particularly among underserved and multilingual populations in San Diego and Santa Clara. “This recognition reflects our commitment to not only serve, but to understand and elevate the communities we care for,” said Dr. Tri T. Nguyen, co-founder and CEO.

To view the full press release, visit https://ibn.fm/k3Zht

About Astiva Health

Astiva Health is a leader in culturally responsive healthcare solutions, committed to bridging healthcare gaps for diverse and underserved populations. With a focus on delivering personalized care, Astiva empowers its members through innovative Medicare Advantage plans, strategic partnerships, and multilingual resources. Serving over 38,000 members across California, Astiva Health is redefining healthcare accessibility and equity through community integration and culturally tailored care.

NOTE TO INVESTORS: The latest news and updates relating to ASTIVA are available in the company’s newsroom at https://ibn.fm/ASTIVA

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000